Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Metformin hydrochloride composition

A technology of metformin hydrochloride and metformin hydrochloride tablets, which is applied in the field of metformin hydrochloride compositions to achieve the effect of reducing adverse reactions in the gastrointestinal tract

Inactive Publication Date: 2021-03-16
DISHA PHARMA GRP
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The technical problem to be solved by the present invention is to reduce the adverse stimulation of metformin hydrochloride to the gastrointestinal tract and reduce the adverse reactions of patients after taking it.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1. Prescription:

[0020] .

[0021] Prepare 1000 tablets according to the preparation method described in the technical scheme.

Embodiment 2

[0022] Embodiment 2. Prescription:

[0023] .

[0024] Prepare 1000 tablets according to the preparation method described in the technical scheme.

Embodiment 3

[0025] Embodiment 3. Prescription:

[0026] .

[0027] Prepare 1000 tablets according to the preparation method described in the technical scheme.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a metformin hydrochloride composition, and belongs to the technical field of pharmacy. The technical scheme is that the metformin hydrochloride composition comprises the following components in parts by weight: 250 parts of metformin hydrochloride, 50-80 parts of soybean phospholipid, 30-50 parts of alginate oligosaccharide, 8-16 parts of hydroxypropyl cellulose, 10-20 parts of aerosil, and 2-4 parts of magnesium stearate. The invention provides the safe and effective metformin hydrochloride composition.

Description

technical field [0001] The invention relates to a metformin hydrochloride composition, which belongs to the technical field of pharmacy. Background technique [0002] Metformin has been used clinically for decades. According to the joint guidelines for the treatment of type 2 diabetes given by the American Diabetes Association and the European Diabetes Association, if there are no special contraindications, patients with type 2 diabetes should take metformin immediately after getting a clear diagnosis, and at the same time carry out lifestyle intervention. As a traditional hypoglycemic drug, metformin is cheap, effective and relatively safe. [0003] Large-scale experiments have proved that metformin only reduces hyperglycemia in diabetic patients, has no effect on physiological blood sugar, and will not cause hypoglycemia when used alone; it can improve insulin sensitivity and promote the utilization of glucose by peripheral tissues; it can delay glucose in the stomach. I...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/155A61K9/30A61K47/24A61K47/26A61K47/38A61K47/04A61K47/12A61P3/10
CPCA61K31/155A61K9/2013A61K9/2018A61K9/2095A61P3/10A61K9/2009A61K9/2054A61K9/282
Inventor 王江涛于华静张友凯王成
Owner DISHA PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products